Ombudsman Welcomes Release Of Adverse Reaction Reports By the European Medicines Agency

By admin at 12 August, 2010, 6:30 am

BRUSSELS, 11 August 2010 – The European Ombudsman, P. Nikiforos Diamandouros, has welcomed the announcement of the European Medicines Agency (EMA) that it will release documents related to a drug used to treat severe forms of acne. The complainant,…

Read the original here:
Ombudsman Welcomes Release Of Adverse Reaction Reports By the European Medicines Agency

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Related posts:

  1. [Editorial] European Medicines Agency—more transparency needed On May 10, 2010, the European Medicines Agency (EMA, formerly...
  2. EMEA notes European Ombudsman’s recommendation to increase transparency Source: EMEA Area: News The European Ombudsman has recommended that...
  3. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions Conclusion One�fifth of all ADRs reported over a decade in...
  4. Your Sense of Agency: Are You In Control of Your Life? Your ability to take action, be effective, influence your own...
  5. [Severe drug hypersensitivity reaction (DRESS syndrome) to doxycycline.] CONCLUSION: This patient is the third case of DRESS to...

Categories : Acne News


No comments yet.

Leave a comment